Last edition
News about "BridGene Biosciences"
BridGene Biosciences Signs Deal with Takeda to Discover Small Molecule Drugs
Under the terms of the collaboration, BridGene will use its chemoproteomics platform, IMTAC™, to discover novel small molecule drug candidates against challenging targets in immunology and neurology.
BridGene Biosciences | 26/02/2025 | By Aishwarya
Under the collaboration, BridGene will use its chemoproteomics platform, IMTAC™, to discover novel small molecule drug candidates against the collaboration targets.
BridGene Biosciences | 05/01/2024 | By Manvi | 184
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy